Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Moreno Senna Jp"'
Publikováno v:
BioTechniques. 26:638-639
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5759154184b629d5c06ea8a4fa0ae10a
https://doi.org/10.2144/99264bm09
https://doi.org/10.2144/99264bm09
The Landscape of Neutralizing Monoclonal Antibodies (nAbs) for Treatment and Prevention of COVID-19.
Autor:
de Almeida Oliveira A; Immunobiological Technology Institute, Bio-Manguinhos/Fiocruz, Oswaldo Cruz Foundation, Avenida Brasil, 4.365, NAPA, Manguinhos, Rio de Janeiro, RJ 21040‑900 Brazil., Praia Borges Freire D; Immunobiological Technology Institute, Bio-Manguinhos/Fiocruz, Oswaldo Cruz Foundation, Avenida Brasil, 4.365, NAPA, Manguinhos, Rio de Janeiro, RJ 21040‑900 Brazil., Rodrigues de Andrade A; Immunobiological Technology Institute, Bio-Manguinhos/Fiocruz, Oswaldo Cruz Foundation, Avenida Brasil, 4.365, NAPA, Manguinhos, Rio de Janeiro, RJ 21040‑900 Brazil., de Miranda Marques A; Immunobiological Technology Institute, Bio-Manguinhos/Fiocruz, Oswaldo Cruz Foundation, Avenida Brasil, 4.365, NAPA, Manguinhos, Rio de Janeiro, RJ 21040‑900 Brazil., da Silva Madeira L; Immunobiological Technology Institute, Bio-Manguinhos/Fiocruz, Oswaldo Cruz Foundation, Avenida Brasil, 4.365, NAPA, Manguinhos, Rio de Janeiro, RJ 21040‑900 Brazil., Moreno Senna JP; Immunobiological Technology Institute, Bio-Manguinhos/Fiocruz, Oswaldo Cruz Foundation, Avenida Brasil, 4.365, NAPA, Manguinhos, Rio de Janeiro, RJ 21040‑900 Brazil., Freitas Brasileiro da Silveira IA; Immunobiological Technology Institute, Bio-Manguinhos/Fiocruz, Oswaldo Cruz Foundation, Avenida Brasil, 4.365, NAPA, Manguinhos, Rio de Janeiro, RJ 21040‑900 Brazil., de Castro Fialho B; Immunobiological Technology Institute, Bio-Manguinhos/Fiocruz, Oswaldo Cruz Foundation, Avenida Brasil, 4.365, NAPA, Manguinhos, Rio de Janeiro, RJ 21040‑900 Brazil.
Publikováno v:
Journal of pharmaceutical innovation [J Pharm Innov] 2023 Feb 20, pp. 1-19. Date of Electronic Publication: 2023 Feb 20.
Autor:
Corrêa Argondizzo AP; Recombinant Technology Laboratory, Technological Development Department, Instituto de Tecnologia Em Imunobiológicos BioManguinhos FIOCRUZ, Avenida Brasil, 4365, Manguinhos, Rio de Janeiro, RJ, 21040-900, Brazil., Saraiva FB; Recombinant Technology Laboratory, Technological Development Department, Instituto de Tecnologia Em Imunobiológicos BioManguinhos FIOCRUZ, Avenida Brasil, 4365, Manguinhos, Rio de Janeiro, RJ, 21040-900, Brazil., Almeida M; Instituto Oswaldo Cruz - IOC FIOCRUZ, Avenida Brasil 4365, Manguinhos, Rio de Janeiro, RJ, 21040-900, Brazil., Nunes Peres AM; Assessoria Clínica, Instituto de Tecnologia Em Imunobiológicos BioManguinhos FIOCRUZ, Avenida Brasil, 4365, Manguinhos, Rio de Janeiro, RJ, 21040-900, Brazil., Moreno Senna JP; Recombinant Technology Laboratory, Technological Development Department, Instituto de Tecnologia Em Imunobiológicos BioManguinhos FIOCRUZ, Avenida Brasil, 4365, Manguinhos, Rio de Janeiro, RJ, 21040-900, Brazil. Electronic address: jprocopio@bio.fiocruz.br.
Publikováno v:
Microbial pathogenesis [Microb Pathog] 2021 Aug; Vol. 157, pp. 105000. Date of Electronic Publication: 2021 May 25.
Autor:
Vieira de Araujo AE; Bio-Manguinhos, Oswaldo Cruz Foundation, Brazilian Ministry of Health, Rio de Janeiro, RJ, Brazil; Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Brazilian Ministry of Health, Rio de Janeiro, RJ, Brazil. Electronic address: anna.vieira@bio.fiocruz.br., Conde LV; Bio-Manguinhos, Oswaldo Cruz Foundation, Brazilian Ministry of Health, Rio de Janeiro, RJ, Brazil. Electronic address: lvcbcn40@gmail.com., da Silva Junior HC; Bio-Manguinhos, Oswaldo Cruz Foundation, Brazilian Ministry of Health, Rio de Janeiro, RJ, Brazil. Electronic address: haroldo.cid@bio.fiocruz.br., de Almeida Machado L; Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Brazilian Ministry of Health, Rio de Janeiro, RJ, Brazil. Electronic address: biolucasmachado@gmail.com., Lara FA; Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Brazilian Ministry of Health, Rio de Janeiro, RJ, Brazil. Electronic address: falara@ioc.fiocruz.br., Chapeaurouge A; Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Brazilian Ministry of Health, Rio de Janeiro, RJ, Brazil. Electronic address: donat.chapeaeurouge@fiocruz.br., Pauer H; National Institute of Science and Technology of Innovation on Diseases of Neglected Populations, Center for Technological Development in Health, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil. Electronic address: heidipauer@gmail.com., Pires Hardoim CC; São Paulo State University, Institute of Biosciences, Coastal Campus of São Vicente, São Paulo, SP, Brazil. Electronic address: cristianehardoim@gmail.com., Martha Antunes LC; Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Brazilian Ministry of Health, Rio de Janeiro, RJ, Brazil; National Institute of Science and Technology of Innovation on Diseases of Neglected Populations, Center for Technological Development in Health, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil. Electronic address: caetano.antunes@fiocruz.br., D'Alincourt Carvalho-Assef AP; Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Brazilian Ministry of Health, Rio de Janeiro, RJ, Brazil. Electronic address: apdca@ioc.fiocruz.br., Moreno Senna JP; Bio-Manguinhos, Oswaldo Cruz Foundation, Brazilian Ministry of Health, Rio de Janeiro, RJ, Brazil. Electronic address: jprocopio@bio.fiocruz.br.
Publikováno v:
Microbes and infection [Microbes Infect] 2021 May-Jun; Vol. 23 (4-5), pp. 104801. Date of Electronic Publication: 2021 Feb 11.
Autor:
da Silva IR; 1 Laboratório de Pesquisa em Infecção Hospitalar (LAPIH), Instituto Oswaldo Cruz-Fiocruz, Rio de Janeiro, Brasil., Aires CAM; 1 Laboratório de Pesquisa em Infecção Hospitalar (LAPIH), Instituto Oswaldo Cruz-Fiocruz, Rio de Janeiro, Brasil.; 2 Departamento de Ciências da Saúde, Universidade Federal Rural do Semi-Árido (UFERSA), Mossoró, Brasil., Conceição-Neto OC; 1 Laboratório de Pesquisa em Infecção Hospitalar (LAPIH), Instituto Oswaldo Cruz-Fiocruz, Rio de Janeiro, Brasil., de Oliveira Santos IC; 1 Laboratório de Pesquisa em Infecção Hospitalar (LAPIH), Instituto Oswaldo Cruz-Fiocruz, Rio de Janeiro, Brasil., Ferreira Pereira N; 1 Laboratório de Pesquisa em Infecção Hospitalar (LAPIH), Instituto Oswaldo Cruz-Fiocruz, Rio de Janeiro, Brasil., Moreno Senna JP; 3 Laboratório de Tecnologia Recombinante (LATER), Instituto de Tecnologia de Imunobiológicos-Fiocruz, Rio de Janeiro, Brasil., Carvalho-Assef APD; 1 Laboratório de Pesquisa em Infecção Hospitalar (LAPIH), Instituto Oswaldo Cruz-Fiocruz, Rio de Janeiro, Brasil., Asensi MD; 1 Laboratório de Pesquisa em Infecção Hospitalar (LAPIH), Instituto Oswaldo Cruz-Fiocruz, Rio de Janeiro, Brasil., Rocha-de-Souza CM; 1 Laboratório de Pesquisa em Infecção Hospitalar (LAPIH), Instituto Oswaldo Cruz-Fiocruz, Rio de Janeiro, Brasil.
Publikováno v:
Microbial drug resistance (Larchmont, N.Y.) [Microb Drug Resist] 2019 Apr; Vol. 25 (3), pp. 394-399. Date of Electronic Publication: 2019 Jan 24.
Autor:
Fajardo Bonin R; Instituto de Tecnologia em Imunobiológicos, Fiocruz, Rio de Janeiro, Brazil., Chapeaurouge A, Perales J, da Silva JG Jr, do Nascimento HJ, D'Alincourt Carvalho Assef AP, Moreno Senna JP
Publikováno v:
Proteomics. Clinical applications [Proteomics Clin Appl] 2014 Dec; Vol. 8 (11-12), pp. 916-23. Date of Electronic Publication: 2014 Aug 28.
Autor:
Lopes RF; Centro de Biotecnologia, Universidade Federal do Rio Grande do Sul, Porto Alegre-RS, Brasil., Moreno Senna JP, Chies JM, Rodrigues JL
Publikováno v:
BioTechniques [Biotechniques] 1999 Apr; Vol. 26 (4), pp. 638-9.